IMCR logo

Immunocore Holdings plc (IMCR) Selling, General & Administrative Expenses

Annual SG&A:

$155.78M+$11.29M(+7.81%)
December 31, 2024

Summary

  • As of today, IMCR annual SG&A is $155.78 million, with the most recent change of +$11.29 million (+7.81%) on December 31, 2024.
  • During the last 3 years, IMCR annual SG&A has risen by +$44.96 million (+40.57%).
  • IMCR annual SG&A is now at all-time high.

Performance

IMCR SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

Quarterly SG&A:

$39.54M-$3.76M(-8.68%)
September 30, 2025

Summary

  • As of today, IMCR quarterly SG&A is $39.54 million, with the most recent change of -$3.76 million (-8.68%) on September 30, 2025.
  • Over the past year, IMCR quarterly SG&A has increased by +$3.64 million (+10.15%).
  • IMCR quarterly SG&A is now -21.86% below its all-time high of $50.60 million, reached on December 31, 2022.

Performance

IMCR Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

TTM SG&A:

-$3.19B-$29.23M(-0.92%)
September 30, 2025

Summary

  • As of today, IMCR TTM SG&A is -$3.19 billion, with the most recent change of -$29.23 million (-0.92%) on September 30, 2025.
  • Over the past year, IMCR TTM SG&A has dropped by -$3.34 billion (-2148.64%).
  • IMCR TTM SG&A is now -762.42% below its all-time high of -$369.75 million.

Performance

IMCR TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

IMCR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.8%+10.2%-2148.6%
3Y3 Years+40.6%+188.4%-3383.7%
5Y5 Years+168.9%--

IMCR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+40.6%-21.9%+188.4%-162.3%at low
5Y5-Yearat high+168.9%-21.9%+188.4%-566.8%at low
All-TimeAll-Timeat high+259.4%-21.9%+258.5%-762.4%at low

IMCR Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$39.54M(-8.7%)
$165.12M(+2.3%)
Jun 2025
-
$43.30M(+7.3%)
$161.48M(+2.9%)
Mar 2025
-
$40.35M(-3.8%)
$156.86M(+0.7%)
Dec 2024
$155.78M(+7.8%)
$41.93M(+16.8%)
$155.77M(+0.1%)
Sep 2024
-
$35.90M(-7.2%)
$155.65M(+7.0%)
Jun 2024
-
$38.68M(-1.5%)
$145.43M(+2.5%)
Mar 2024
-
$39.26M(-6.1%)
$141.87M(+4.7%)
Dec 2023
$144.50M(+17.4%)
$41.81M(+62.8%)
$135.47M(-6.1%)
Sep 2023
-
$25.67M(-26.9%)
$144.26M(+9.0%)
Jun 2023
-
$35.12M(+6.9%)
$132.30M(+9.5%)
Mar 2023
-
$32.86M(-35.1%)
$120.77M(+5.1%)
DateAnnualQuarterlyTTM
Dec 2022
$123.06M(+11.0%)
$50.60M(+269.1%)
$114.87M(+18.3%)
Sep 2022
-
$13.71M(-41.9%)
$97.11M(-12.5%)
Jun 2022
-
$23.60M(-12.5%)
$111.02M(-8.0%)
Mar 2022
-
$26.96M(-17.9%)
$120.71M(-0.7%)
Dec 2021
$110.82M(+77.8%)
$32.84M(+18.9%)
$121.58M(+13.1%)
Sep 2021
-
$27.62M(-17.0%)
$107.45M(+34.6%)
Jun 2021
-
$33.29M(+19.6%)
$79.83M(+71.5%)
Mar 2021
-
$27.83M(+48.7%)
$46.54M(+148.7%)
Dec 2020
$62.34M(+7.6%)
$18.71M(+69.7%)
$18.71M(+69.7%)
Dec 2019
$57.93M(+33.7%)
$11.03M
$11.03M
Dec 2018
$43.34M
-
-

FAQ

  • What is Immunocore Holdings plc annual SG&A?
  • What is the all-time high annual SG&A for Immunocore Holdings plc?
  • What is Immunocore Holdings plc annual SG&A year-on-year change?
  • What is Immunocore Holdings plc quarterly SG&A?
  • What is the all-time high quarterly SG&A for Immunocore Holdings plc?
  • What is Immunocore Holdings plc quarterly SG&A year-on-year change?
  • What is Immunocore Holdings plc TTM SG&A?
  • What is the all-time high TTM SG&A for Immunocore Holdings plc?
  • What is Immunocore Holdings plc TTM SG&A year-on-year change?

What is Immunocore Holdings plc annual SG&A?

The current annual SG&A of IMCR is $155.78M

What is the all-time high annual SG&A for Immunocore Holdings plc?

Immunocore Holdings plc all-time high annual SG&A is $155.78M

What is Immunocore Holdings plc annual SG&A year-on-year change?

Over the past year, IMCR annual SG&A has changed by +$11.29M (+7.81%)

What is Immunocore Holdings plc quarterly SG&A?

The current quarterly SG&A of IMCR is $39.54M

What is the all-time high quarterly SG&A for Immunocore Holdings plc?

Immunocore Holdings plc all-time high quarterly SG&A is $50.60M

What is Immunocore Holdings plc quarterly SG&A year-on-year change?

Over the past year, IMCR quarterly SG&A has changed by +$3.64M (+10.15%)

What is Immunocore Holdings plc TTM SG&A?

The current TTM SG&A of IMCR is -$3.19B

What is the all-time high TTM SG&A for Immunocore Holdings plc?

Immunocore Holdings plc all-time high TTM SG&A is -$369.75M

What is Immunocore Holdings plc TTM SG&A year-on-year change?

Over the past year, IMCR TTM SG&A has changed by -$3.34B (-2148.64%)
On this page